NCT00724490

Brief Summary

The purpose of the study was to evaluate whether a unilateral Deep Brain Stimulation of the right Nucleus Accumbens could lead to a more than 35% reduction of symptoms in patients with a treatment resistant Obsessive Compulsive Disorder within two years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2007

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 29, 2008

Completed
Last Updated

July 29, 2008

Status Verified

July 1, 2008

Enrollment Period

3.6 years

First QC Date

July 25, 2008

Last Update Submit

July 28, 2008

Conditions

Keywords

Deep Brain StimulationObsessive Compulsive DisorderNucleus Accumbens

Outcome Measures

Primary Outcomes (1)

  • Yale-Brown Obsessive Compulsive Scale

    Baseline (preoperative), 1week, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months

Secondary Outcomes (1)

  • Beck Depression Inventory

    Baseline (preoperative), 1 week, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months

Interventions

Unilateral Deep Brain Stimulation in the right Nucleus Accumbens

Also known as: Model 3387 DBS Lead, Medtronic, Minneapolis, USA

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obsessive compulsive disorder (according to DSM IV-criteria) as the primary psychiatric diagnosis
  • severity level of OCD more than 25 on the Yale-Brown Obsessive Compulsive Scale
  • course of illness had to have been present for at least five years in a chronic or progressive form despite any treatment trials (treatment resistance)
  • treatment resistance: at least two serotonin reuptake inhibitors (SSRI´s), or one SSRI and clomipramine in sufficient dosages for at least 10 weeks, an augmentation trial with lithium, buspirone or a neuroleptic lasting at least 10 weeks, and complete cognitive-behavioral psychotherapy, including "exposure and response prevention" of a minimum of 20 sessions with a documented lack of efficiency
  • the ability to give written and informed consent

You may not qualify if:

  • co-morbid psychotic disorder according to DSM-IV criteria
  • suicidal tendencies in the last 6 months
  • history of cerebral trauma
  • clinically relevant internal or neurological disorder
  • substance misuse or dependence in the last six months
  • ineligibility to fulfill the neurosurgical and anesthesiological preconditions for the implantation of a DBS
  • pregnancy
  • lactation period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, University of Cologne

Cologne, North Rhine-Westphalia, 50924, Germany

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Interventions

Deep Brain Stimulation

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsSurgical Procedures, Operative

Study Officials

  • Joachim Klosterkötter, MD

    Department of Psychiatry, Head of Department, University of Cologne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 25, 2008

First Posted

July 29, 2008

Study Start

February 1, 2004

Primary Completion

September 1, 2007

Study Completion

February 1, 2008

Last Updated

July 29, 2008

Record last verified: 2008-07

Locations